natgillin/translations-raw huggingface dataset:
Co-administration of ribavirin and didanosine and/or stavudine is not recommended due to the risk of lactic acidosis (a build-up of lactic acid in the body) and pancreatitis.
Sočasna uporaba ribavirina in didanozina in/ ali stavudina ni priporočljiva zaradi tveganja za pojav laktacidoze (kopičenje mlečne kisline v telesu) in pankreatitisa.
HOW TO USE VIRAFERONPEG
KAKO UPORABLJATI ZDRAVILO VIRAFERONPEG
Your doctor has prescribed ViraferonPeg specifically for you and your current condition; do not share this medicine with anyone else.
Ne smete ga dati nikomur drugemu.
Your doctor has determined your dose of ViraferonPeg based on your weight.
Zdravnik vam je odmerek zdravila ViraferonPeg določil glede na vašo telesno maso.
Combination treatment ViraferonPeg, when given with ribavirin capsules, is usually given at a dose of 1.5 microgram/kg once a week.
Kombinirano zdravljenje Kadar jemljete zdravilo ViraferonPeg skupaj s kapsulami ribavirina, je odmerek običajno 1, 5 mikrograma/ kg enkrat na teden.
Ribavirin capsules are taken every day, morning and evening.
Kapsule ribavirina jemljite vsak dan, zjutraj in zvečer.
The number of ribavirin capsules you take depends on your weight.
Število kapsul ribavirina, ki jih boste jemali, je odvisno od vaše telesne mase.
- If you weigh less than 65 kg, take 2 capsules in the morning and 2 in the evening (total of
- Če tehtate manj kot 65 kg, vzemite 2 kapsuli zjutraj in 2 zvečer (skupaj 800 mg
800 mg each day).
na dan).
- If you weigh between 65 and 85 kg, take 2 capsules in the morning and 3 in the evening (total of
- Če tehtate med 65 – 85 kg, vzemite 2 kapsuli zjutraj in 3 zvečer (skupaj 1. 000 mg na dan).
- If you weigh between 86 and 105 kg, take 3 capsules in the morning and 3 in the evening (total
- Če tehtate med 85 – 105 kg, vzemite 3 kapsule zjutraj in 3 zvečer (skupaj 1. 200 mg na dan).
- If you weigh more than 105 kg, take 3 capsules in the morning and 4 in the evening (total of
- Če tehtate več kot 105 kg, vzemite 3 kapsule zjutraj in 4 kapsule zvečer (skupaj 1. 400 mg na
1,400 mg each day).
dan).
In first-time users, the combination treatment is continued for 3 to 6 months, and sometimes for one year depending on your physicians judgement.
Pri bolnikih, ki prejemajo to zdravilo prvič, naj kombinirano zdravljenje traja 3 do 6 mesecev, včasih pa tudi eno leto, po presoji vašega zdravnika.
Take notice of the respective informing texts of ribavirin containing medicinal products.
Upoštevajte ustrezna informativna besedila za zdravila, ki vsebujejo ribavirin.
For HCV/HIV co-infected patients, the duration of treatment is 48 weeks.
Pri bolnikih, ki imajo sočasno okužbo z virusoma HCV in HIV, traja zdravljenje 48 tednov.
270 In patients who have not responded previously or relapsed, the treatment should continue for one year (contingent upon the response after the first 12 weeks of therapy).
278 Pri bolnikih, ki se prej niso odzvali ali ki imajo ponovitev bolezni, naj zdravljenje traja eno leto (pod pogojem, da se odzovejo nanj po prvih 12 tednih).
ViraferonPeg alone:
ViraferonPeg v monoterapiji:
ViraferonPeg, when given alone, is usually given at a dose of 0.5 or 1.0 microgram/kg once a week, for at least 6 months, and possibly for 1 year.
Kadar se zdravilo ViraferonPeg uporablja samostojno, znaša običajni odmerek 0, 5 ali 1, 0 mikrogram/ kg enkrat na teden najmanj 6 mesecev, lahko pa tudi do 1 leta.
If you have kidney disease, your dose may be lower, depending upon your kidney function.
Če imate ledvično bolezen, bo vaš odmerek lahko manjši, odvisno od delovanja vaših ledvic.
ViraferonPeg alone was not studied in HCV/HIV co-infected patients.
Pri bolnikih, sočasno okuženih z virusoma HCV in HIV, niso proučevali uporabe samega zdravila ViraferonPeg.
All patients:
Vsi bolniki:
If you are injecting ViraferonPeg yourself, please be sure that the dose that has been prescribed for you is clearly provided on the package of medicine you receive.
Če si zdravilo ViraferonPeg injicirate sami, morate vedno preveriti, ali je na pakiranju zdravila, ki ga jemljete, jasno naveden odmerek, ki vam ga je predpisal zdravnik.
If you have the impression that the effect of ViraferonPeg is too strong or too weak, talk to your doctor or pharmacist.
Če menite, da je učinek zdravila ViraferonPeg premočan ali prešibak, se posvetujte s svojim zdravnikom ali farmacevtom.
ViraferonPeg is intended for subcutaneous use.
ViraferonPeg je namenjen subkutani uporabi.
This means that it is injected through a short injection needle into the fatty tissue just under your skin.
To pomeni, da se s kratko injekcijsko iglo injicira v maščevje tik pod kožo.
If you are injecting this medicine yourself, you will be instructed how to prepare and give the injection.
Če si zdravilo injicirate sami, boste dobili navodila, kako pripraviti in si dati injekcijo.
Detailed instructions for subcutaneous administration are provided with this leaflet (see How to self-inject ViraferonPeg at the end of the package leaflet).
Podrobna navodila za podkožno injiciranje so priložena tudi temu vložnemu listku (glejte poglavje Kako si sami injicirate ViraferonPeg na koncu navodil).
Look carefully at the reconstituted solution prior to administration.
Pred uporabo si rekonstituirano raztopino natančno oglejte.
Do not use if there is discolouration of the reconstituted solution or if particulate matter is present.
Zdravila ViraferonPeg ne smete uporabljati, če je rekonstituirana raztopina obarvana ali če so v njej vidni delci.
Inject ViraferonPeg once each week on the same day.
Zdravilo ViraferonPeg si injicirajte enkrat na teden, vedno na isti dan.
Always use ViraferonPeg exactly as your doctor has told you.
Pri uporabi zdravila ViraferonPeg natančno upoštevajte zdravnikova navodila.
If you use more ViraferonPeg than you should Tell your doctor or healthcare professional as soon as possible.
Če ste uporabili večji odmerek zdravila ViraferonPeg, kot bi smeli Čimprej povejte svojemu zdravniku ali drugemu zdravstvenemu delavcu.
If you forget to take ViraferonPeg Take the dose as soon as you remember, then continue your treatment as usual.
Če ste pozabili vzeti zdravilo ViraferonPeg Vzemite odmerek, takoj ko se spomnite, potem pa zdravljenje nadaljujte kot ponavadi.
Like all medicines, ViraferonPeg can cause side effects, although not everybody gets them.
Kot vsa zdravila ima lahko tudi zdravilo ViraferonPeg neželene učinke, ki pa se ne pojavijo pri vseh bolnikih.
Some people get depressed when taking ViraferonPeg alone or in combination treatment with ribavirin, and in some cases people had suicidal thoughts or aggressive behaviour (sometimes directed against others).
Nekateri bolniki postanejo med jemanjem zdravila ViraferonPeg samega ali v okviru kombiniranega zdravljenja z ribavirinom depresivni.
Be sure to seek emergency care if you notice that you are becoming depressed or have suicidal thoughts or change in your behaviour.
Če opazite, da postajate depresivni oz. imate samomorilne misli oz. se je vaše obnašanje spremenilo, morate poiskati urgentno medicinsko pomoč.
271 blood or clots in stool (or black, tarry stool); fever or chills beginning after a few weeks of treatment, pain in your lower back or side; difficulty or inability to pass urine, painful or inflamed muscles (sometimes severe); problems with your eyes or your eyesight or hearing; severe or painful reddening of your skin or mucous membrane, severe bleeding from your nose.
279 Takoj, ko opazite katerega od naslednjih neželenih učinkov, se posvetujte s svojim zdravnikom: bolečine v prsih, spremenjen srčni utrip, težave z dihanjem, (vključno s težkim dihanjem), zmedenost, depresija, samomorilne misli, halucinacije, občutek omrtvičenosti ali mravljincev, omotica, konvulzije (epileptični napadi), težave s spanjem, mišljenjem ali koncentracijo, težave ostati buden, hude želodčne bolečine ali krče; kri ali krvni strdki v blatu (ali črno smolasto blato), zvišana telesna temperatura ali mrzlica, ki se začne po nekaj tednih zdravljenja, bolečine v križu ali ob strani; težave pri uriniranju ali nezmožnost uriniranja, bolečine v mišicah ali vnetje mišic (včasih hudo) težave z očmi, vidom ali sluhom, močna ali boleča pordelost kože ali sluznic, hude krvavitve iz nosu.
Your doctor will test your blood to ensure that your white blood cell (cells that fight infection) and red blood cell (cells that carry oxygen) counts, platelets (blood clotting cells) and other laboratory values are at acceptable levels.
Zdravnik vas bo napotil na krvne preiskave, da preveri, ali so vrednosti števila belih krvničk (celice, ki se bojujejo proti okužbi), rdečih krvničk (celice, ki prenašajo kisik po telesu) in trombocitov (celic, ki sodelujejo pri strjevanju krvi) ter drugih laboratorijskih izvidov sprejemljive.
Other side effects that may occur with the combination of ViraferonPeg and ribavirin capsules include:
Drugi neželeni učinki, ki se lahko pojavijo pri uporabi kombinacije zdravila ViraferonPeg in kapsul ribavirina so:
Very commonly reported side effects (greater than or equal to 1 in every 10 patients):
Zelo pogosto prijavljeni neželeni učinki (pogostnost enaka ali večja od 1 na vsakih 10 bolnikov):
Irritation or redness (and rarely, skin damage) at the site of injection, headache, tired feeling, shaking chills, fever, flu-like symptoms, weakness, loss of weight, nausea, loss of appetite, diarrhoea or loose stools, stomach pain, vomiting, muscle aches, pain in joints and muscles, feeling depressed, irritability, trouble falling asleep or staying asleep, feeling anxious or nervous, difficulty concentrating, mood swings, hair loss, itching, dry skin, sore throat, coughing, difficult breathing, dizziness, virus infection, rash, and dry mouth.
Draženje ali pordelost (in redko poškodbe kože) na mestu injiciranja, glavobol, občutek utrujenosti, mrzlica s tresenjem, zvišana telesna temperatura, gripozni simptomi, šibkost, hujšanje, slabost, izguba teka, driska ali mehko blato, bolečine v želodcu, bruhanje, mišična občutljivost, bolečine v sklepih in mišicah, depresija, razdražljivost, težave z uspavanjem ali zbujanje, tesnoba ali živčnost, težave s koncentracijo, spremembe razpoloženja, izpadanje las, srbenje, suha koža, vneto grlo, kašelj, oteženo dihanje, vrtoglavica, virusne okužbe, izpuščaj in suha usta.
Commonly reported side effects (at least 1 in every 100 patients, but less than 1 in every 10 patients):
Pogosto prijavljeni neželeni učinki (pojavijo se pri najmanj 1 na vsakih 100 bolnikov, vendar pri manj kot 1 na vsakih 10 bolnikov):
Increased sweating, chest pain, pain on the right side around your ribs, numbness, pain or tingling feeling, change in thyroid gland activity (which may make you feel tired or, less commonly, energetic), stomach upset, rapid heart rate, agitation, nervousness, difficult or irregular menstrual period.
Povečano znojenje, bolečine v prsih, bolečina na desni strani pod rebri, občutek omrtvičenosti, bolečina ali mravljinci, spremembe delovanja žleze ščitnice (zaradi katerih boste lahko utrujeni ali redkeje polni energije), težave z želodcem, hitro bitje srca, vznemirjenost, živčnost, težavne ali neredne menstruacije.
Less common are pain at the place of injection, flushing, low or high blood pressure, dry or teary eyes, redness of skin or skin disorders, psoriasis, hives, nail disorder, feeling unwell, feeling faint, poor coordination, confusion, increased or decreased sensitivity to touch, tense muscles, arthritis, bruising, loss of interest in activities including sex, sexual problem, unusual dreams, shaky hands, vertigo (spinning feeling), increased appetite, heartburn, intestinal gas (flatus), constipation, hemorrhoids, red or bleeding gums, redness or sores in mouth, change in taste, changes in hearing or ringing in ears, thirst, changed behaviour or aggressive behaviour (sometimes directed against others), feeling sleepy, cold sores, fungal or bacterial infections, irritation of prostate gland, increased need to pass urine, ear or respiratory infections, sinusitis, stuffy or runny nose, abnormal hair texture, sensitivity to sunlight, migraine headache, eye pain or infection, blurred vision, puffy face, puffy hands or feet, enlarged liver, problem affecting ovary or vagina, pain in breast, difficulty in speaking and swollen glands.
Med manj pogostimi neželenimi učinki so bolečine na mestu injiciranja, navali vročine, znižan ali zvišan krvni tlak, suhe ali solzne oči, pordelost kože ali druge kožne spremembe, psoriaza, koprivnica, motnje nohtov, slabo počutje, omedlevica, slaba koordinacija, zmedenost, povečana ali zmanjšana občutljivost za dotik, napete mišice, artritis, podplutbe, izguba zanimanja za spolnost, težave s spolnostjo, nenavadne sanje, tresoče roke, vrtoglavica (občutek vrtenja), povečan tek, zgaga, napenjanje in vetrovi (flatulenca), zaprtje, hemoroidi, pordelost ali krvavitve iz dlesni, pordelost ali afte v ustih, spremembe okusa, spremembe sluha ali zvonjenje v ušesih, žeja, poskus samomora spremenjeno obnašanje ali agresivno obnašanje (včasih odkrito proti drugim), zaspanost, herpes, glivične ali bakterijske okužbe, draženje prostate, povečana potreba po odvajanju vode, okužbe ušes ali dihal, sinusitis, zamašen nos ali izcedek iz nosa, nenormalna zgradba las, občutljivost na sončno svetlobo, migrenski glavobol, boleče ali vnete oči, zameglen vid, oteklost obraza, oteklost rok ali stopal, povečana jetra, težave z jajčniki ali vagino, bolečine v dojkah, težave z govorom in otekle bezgavke.
The following rare and very rare events have been reported with ViraferonPeg:
Pri uporabi zdravila ViraferonPeg so poročali o naslednjih redkih in zelo redkih učinkih:
Rarely reported side effects (at least 1 in every 10,000 patients, but less than 1 in every 1,000 patients):
Redko prijavljeni neželeni učinki (pojavijo se pri najmanj 1 na vsakih 10. 000 bolnikov, vendar pri manj kot 1 na vsakih 1. 000 bolnikov):
Diabetes, abnormal heart rhythm, inflammation of pancreas, inflammation and degeneration of muscle tissue and peripheral nerves, kidney problems and seizures.
Sladkorna bolezen, motnje srčnega ritma, vnetje trebušne slinavke, vnetje in degeneracija mišičnega tkiva in perifernih živcev, ledvične težave in epileptični napadi.
Very rarely reported side effects (less than 1 in every 10,000 patients):
Zelo redko prijavljeni neželeni učinki (ki se pojavljajo pri manj kot 1 na vsakih 10. 000 bolnikov):
Very rarely sarcoidosis (a disease characterised by persistent fever, weight loss, joint pain and swelling, skin lesions and swollen glands) has been reported.
Zelo redko so poročali o sarkoidozi (bolezni, za katero so značilni trdovratna zvišana temperatura, hujšanje, sklepne bolečine in otekanje, kožne spremembe in otekle bezgavke).
Loss of consciousness has occurred very rarely with alpha interferons, mostly in elderly patients treated at high doses.
Zelo redko je pri uporabi interferonov alfa nastopila izguba zavesti, večinoma pri starejših bolnikih, zdravljenih z velikimi odmerki.
Cases of stroke (cerebrovascular events) have been reported.
Poročali so tudi o primerih možganske kapi (cerebrovaskularni inzult).
Check with your doctor immediately if you have any of these symptoms or any other symptoms that are troubling.
Če imate katerega od teh simptomov ali če imate kak drug moteč simptom, se nemudoma posvetujte s svojim zdravnikom.
Very rarely, ViraferonPeg alone or in combination with ribavirin may cause aplastic anaemia.
280 Zelo redko lahko zdravilo ViraferonPeg v monoterapiji ali v kombinirani terapiji z ribavirinom povzroči aplastično anemijo.
Additionally, the following events have been reported with ViraferonPeg: facial palsy (weakness and slumping on one side to the face) and severe allergic reactions such as angioedema (an allergic skin disease characterized by patches of circumscribed swelling involving the skin and its subcutaneous layers, the mucous membranes, and sometimes the internal organs), toxic epidermal
Poleg tega so pri zdravilu ViraferonPeg poročali o naslednjih neželenih učinkih: paraliza obraznega živca (šibkost mišic in visenje ene strani obraza) in hude alergijske reakcije, na primer toksična epidermalna nekroliza, Stevens- Johnsonov sindrom ali multiformni eritem (spekter izpuščajev različnih stopenj jakosti, vključno s smrtjo, ki so lahko povezani s pojavom mehurjev na ustni, nosni ali očesni sluznici ter na drugih sluznicah in luščenje prizadetega predela kože).
Additionally, Vogt-Koyanagi-Harada syndrome (an autoimmune inflammatory disorder affecting the eyes, skin and the membranes of the ears, brain and spinal cord) has been reported with ViraferonPeg use.
Poleg tega so pri uporabi zdravila ViraferonPeg poročali tudi o pojavu sindroma Vogt- Koyanagi - Harada (avtoimunska vnetna bolezen, ki prizadene oči, kožo in ušesne membrane ter ovojnice možgan in hrbtenjače).
When ViraferonPeg is used alone, some of these effects are less likely to occur, and some have not occurred at all.
Kadar se zdravilo ViraferonPeg uporablja samostojno, je verjetnost pojava nekaterih od naštetih neželenih učinkov manjša, nekateri pa se sploh nikoli niso pojavili.
If you are receiving HAART, the addition of ViraferonPeg and ribavirin may increase your risk of lactic acidosis, liver failure, and development of blood abnormalities (reduction in number of red blood cells which carry oxygen, certain white blood cells that fight infection, and blood clotting cells called platelets).
Če se zdravite s shemo HAART, lahko dodatek zdravila ViraferonPeg in ribavirina pri vas poveča tveganje za pojav laktacidoze, jetrne odpovedi in nastanka krvnih motenj (zmanjšanje števila rdečih krvničk, ki prenašajo kisik po krvi, določenih belih krvničk, s katerimi se telo bojuje proti okužbam, in celic za strjevanje krvi, ki jim pravimo trombociti).
The following other side effects (not listed above) have occurred with the combination of ViraferonPeg and ribavirin capsules (adults) in HCV/HIV co-infected patients receiving HAART: oral candidiasis (oral thrush), defective metabolism of fat, CD4 lymphocytes decreased, appetite decreased, back pain, hepatitis, limb pain, and various laboratory blood values abnormalities.
Naslednji drugi neželeni učinki (ki niso navedeni zgoraj) so se pojavili pri uporabi kombinacije zdravila ViraferonPeg in kapsul ribavirina (odrasli) pri bolnikih, ki so bili sočasno okuženi z virusoma HCV in HIV in so prejemali zdravljenje s shemo HAART: peroralna kandidiaza (soor v ustih), motnje presnove maščob, zmanjšano število limfocitov CD4, povečan tek, bolečine v hrbtu, hepatitis, bolečine v udih in nenormalni izvidi različnih laboratorijskih preiskav krvi.
HOW TO STORE VIRAFERONPEG
SHRANJEVANJE ZDRAVILA VIRAFERONPEG
Do not use ViraferonPeg after the expiry date which is stated on the carton.
Zdravila ViraferonPeg ne smete uporabljati po datumu izteka roka uporabnosti, ki je naveden na škatli.
Do not use ViraferonPeg if you notice discolouration of the powder.
Ne uporabljajte zdravila ViraferonPeg, če opazite obarvanje praška.
- The active substance is peginterferon alfa-2b, 50 micrograms/0.5 ml.
- Zdravilna učinkovina je peginterferon alfa- 2b, 50 mikrogramov/ 0, 5 ml.
Powder: disodium phosphate, anhydrous; sodium dihydrogen phosphate dihydrate, sucrose and polysorbate 80; Solvent: water for injections 0.7 ml/ampoule.
Prašek: natrijev hidrogenfosfat, brezvodni; natrijev dihidrogenfosfat dihidrat, saharoza in polisorbat 80; Vehikel: voda za injekcije 0, 7 ml/ ampulo.
What ViraferonPeg looks like and contents of the pack
281 Izgled zdravila ViraferonPeg in vsebina pakiranja
273 The white powder is contained in a 2 ml glass vial and the clear and colourless solvent is presented in a 2 ml glass ampoule.
Farmacevtska oblika je: prašek in vehikel za raztopino za injiciranje Bel prašek je v 2 ml stekleni viali, bister in brezbarven vehikel pa v 2 ml stekleni ampuli.
ViraferonPeg 50 micrograms is available in different pack sizes:
ViraferonPeg 50 mikrogramov je na voljo v različnih velikostih pakiranj:
- 6 vials of powder for solution for injection and 6 ampoules of solvent for parenteral use;
- 6 vial praška za raztopino za injiciranje in 6 ampul vehikla za parenteralno uporabo;
- 12 vials of powder for solution for injection, 12 ampoules of solvent for parenteral use,
- 12 vial praška za raztopino za injiciranje in 12 ampul vehikla za parenteralno
12 injection syringes, 24 injection needles and 12 cleansing swabs.
uporabo, 12 injekcijskih brizg, 24 injekcijskih igel in 12 čistilnih tamponov.
SP Labo N.V., Industriepark, 30, B-2220 Heist-op-den-Berg, Belgium
SP Labo N. V., Industriepark, 30, B- 2220 Heist- op- den- Berg, Belgija
„Н.Й.Вапцаров” 53А, ет.
"Проф.
2 BG-София 1407 Тел.: +359 2 806 301
Милко Бичев "№ 7, ет. 3 BG- София 1504 Тел.: +359 2 944 1073
Österreich Am Euro Platz 2 A-1120 Wien Tel: + 43-(0) 1 813 12 31
Österreich Badener Strasse 23 A- 2514 Traiskirchen Tel: + 43 - (0) 2252 502- 0
274 Ελλάδα Αγίου Δημητρίου 63 GR-174 55 Άλιμος Tηλ.: + 30-210 98 97 300
282 Ελλάδα Αγίου Δημητρίου 63 GR- 174 55 Άλιμος Tηλ.: + 30- 210 98 97 300
Polska Ul.
Polska Al.
Tasmowa 7 PL-02-677 Warszawa Tel.: + 48-(0)22 478 41 50
Jerozolimskie 195a PL- 02- 222 Warszawa Tel.: + 48 - (0) 22 478 41 50
Suomi/Finland PL 86/PB 86 FIN-02151 Espoo/Esbo Puh/Tel: + 358-(0)20-7570 300
Suomi/ Finland PL 3/ PB 3 FIN- 02201 Espoo/ Esbo Puh/ Tel: + 358 - (0) 20- 7570 300
Detailed information on this product is available on the web -site of the Europe an Medicines Agency (EMEA) http://www.emea.europa.eu
Podrobne informacije o zdravilu so objavljene na spletni strani Evropske agencije za zdravila (EMEA) http: // www. emea. europa. eu /.
275 HOW TO SELF-INJECT VIRAFERONPEG?
283 KAKO SI SAMI INJICIRATE ZDRAVILO VIRAFERONPEG?
The following instructions explain how to inject ViraferonPeg yourself.
Naslednja navodila pojasnjujejo, kako naj si sami injicirate zdravilo ViraferonPeg.
Your doctor or his/her assistant will instruct you how to self- inject ViraferonPeg.
Vaš zdravnik ali njegov pomočnik vas bo naučil, kako naj si zdravilo ViraferonPeg injicirate sami.
Do not attempt to inject yourself unless you are sure you understand the procedure and requirement of self-injection.
Ne skušajte si injicirati zdravila, če niste prepričani, da razumete postopek in vse zahteve za samoinjiciranje.
Preparation Collect necessary items before you begin:
Priprava Pred začetkom si pripravite vse potrebno:
- a vial of ViraferonPeg powder for injection;
- viala zdravila ViraferonPeg prašek za injekcije;
- an ampoule of solvent for ViraferonPeg (water for injections);
- ampula vehikla oz. topila za zdravilo ViraferonPeg (voda za injekcije);
- a 1 ml syringe;
- 1 ml brizga;
- a long needle (for example 0.8 × 40 mm [21 gauge 1.5 inch]) to be used to add water for
0, 8 × 40 mm), ki jo boste uporabili za dodajanje vode za injekcije v vialo s
injections to the ViraferonPeg powder vial;
praškom ViraferonPeg; kratka igla (npr.
- a short needle (for example 0.3 × 13 mm [30 gauge 0.5 inch]) for the subcutaneous injection;
0, 3 × 13 mm) za subkutano injiciranje;
Reconstituting ViraferonPeg powder for injection Before reconstitution, ViraferonPeg may appear either as a white, tablet-shaped solid that is whole or in pieces, or as a white powder.
Rekonstitucija ViraferonPeg praška za injekcije Pred rekonstitucijo je zdravilo ViraferonPeg videti bodisi kot bela trdna snov v obliki tablete, ki je cela ali v koščkih, ali kot bel prašek.
Remove the syringe from the wrapping.
Vzemite brizgo iz ovojnine.
Take the long needle and place it firmly on to the tip of the syringe.
Vzemite dolgo iglo in jo trdno postavite na vrh brizge.
Remove the needle guard without touching the needle and keep the syringe with the needle in your hand.
Odstranite zaščitni pokrovček z igle, ne da bi se dotaknili igle, in brizgo z iglo obdržite v roki.
When the total amount of solvent is combined with the full amount of ViraferonPeg powder, the solution will be at the correct concentration to measure your dose (i.e., the labelled amount is contained in 0.5 ml).
0, 5 ml vsebuje označeno količino učinkovine).
A small volume is lost during preparation of ViraferonPeg for injection and when the dose is measured and injected.
Med pripravo zdravila ViraferonPeg za injiciranje se izgubi manjša količina vsebine, ko pripravljamo odmerek in ga injiciramo.